Lars Erik Kristensen

Lars Erik Kristensen is Chief Scientific Officer at the Parker Institute (Copenhagen, Denmark). Lars Erik Kristensen is MD from the University of Copenhagen (Copenhagen, Denmark), and specialist in internal medicine, rheumatology from Lund University (Lund, Sweden). His current research activities are focussed on efficacy and tolerability of anti-TNF treatment and other second-generation biologicals in chronic arthritis both in controlled clinical trial settings and observational cohort studies.